Patients en Réseau
- Company typePrivate
- Founded2014
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2C
- OfferingServices
Patients en Réseau firmographics
Firmographics- Name
- Patients en Réseau
- Legal name
- Association Patients en réseau
- Website
- https://patientsenreseau.fr
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Patients en Réseau industry classification
Industry- Product category
- Patient Support Services
- NAICS
- Individual and Family Services (6241), Other Individual and Family Services (62419), Social Assistance (624)
- SIC
- Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Health & Support Communities (BPAMABAL)
- akta.pro secondary industries
- Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD), Patient Education, Content & Personalized Journey Orchestration (HLACAEAE), Health, Wellness & Patient Communities (MPACAJAL)
Keywords
Where Patients en Réseau is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Patients en Réseau business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Membership Dues: Annual membership fee of 20 euros per year, providing members with voting rights in the association and access to participate in its governance and development.
- Donations: The association accepts donations from individuals who support its mission, facilitated through the HelloAsso platform.
- Institutional Support and Partnerships: The association receives institutional support from pharmaceutical companies and healthcare institutions, which help fund projects and programs.
- Boutique / Product Sales: Sale of products (boutique items) such as communication kits and the 'Les Funambules de la Vie' album to support the association's activities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Annual Membership - 20€ per year |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels9 records
Patients en Réseau product offering
Product offeringCore offering
Patients en Réseau operates free, anonymous and moderated secure private social networks for cancer patients and their caregivers across five disease-specific communities (breast, lung, gynecological, colorectal cancers, and caregivers). The association complements these communities with digital remote patient monitoring tools (AKO@dom, AKO@pro, AKO@pharma) developed with Continuum+, an educational serious game (Mon Immuno Poumon), webconferences (LinK) and informational video content. All content is validated by multidisciplinary scientific committees drawn from leading French cancer institutions, and the platforms are accessible via web and mobile applications to all French speakers.
Product overview
Patients en Réseau operates a portfolio of secure private social networks dedicated to cancer patients and their caregivers, anchored by Mon Réseau Cancer platforms covering breast cancer, lung cancer, gynecological cancers, colorectal cancer, and caregiver support. The association complements these core networks with digital health solutions (AKO@dom, AKO@pro, AKO@pharma for remote monitoring), educational tools (Mon Immuno Poumon serious game), and information programs (LinK webconferences, Ma vie avec la stomie video series). All networks offer anonymity, are free, moderated by expert patients, and accessible via website and mobile applications.
Differentiator
Problem solved
Functional benefit
Brands
- Mon Immuno Poumon: Serious game for patients treated with immunotherapy for lung cancer
- LinK
- AKO@dom
- AKO@pro
- AKO@pharma
- Ma vie avec la stomie
Products and services
- Mon Réseau Cancer du Sein Secure private social network for breast cancer patients and their loved ones, enabling peer exchange, reliable information sharing, and access to practical resources.
- Mon Réseau Cancer du Poumon Secure private social network for lung cancer patients and their loved ones, facilitating daily support, information exchange, and clinical research participation, with a focus on immunotherapy and targeted therapies.
- Mon Réseau Cancer Gynéco Secure private social network covering endometrial, ovarian, cervical, vaginal, and vulvar cancers, serving patients and their loved ones.
- Mon Réseau Cancer Colorectal Secure private social network for colorectal cancer patients (colon, rectum, anal canal) and their loved ones, supporting daily life management and promoting prevention and screening, including stoma content.
- Mon Réseau Cancer Proches Online space dedicated to caregivers and loved ones of cancer patients, providing peer support, reliable information, practical resources, and combating caregiver isolation.
- Mon Immuno Poumon Educational serious game helping lung cancer patients understand immunotherapy treatment, recognise side effects, learn self-monitoring, and know appropriate responses.
- AKO@dom Home care coordination solution connecting hospital and city-based care teams via the Continuum+ platform, with liberal nurses monitoring metastatic cancer patients on oral cancer therapies during the first three months of treatment.
- AKO@pro Remote patient monitoring application enabling self-evaluation of health status for patients on oral therapies, allowing healthcare professionals to exchange with patients and take necessary measures without requiring in-person visits.
- AKO@pharma Pharmacy-based follow-up through pharmaceutical consultations in oncology, leveraging community pharmacists for patient support and adverse event monitoring.
Quantifiable outcome
- Mon Réseau Cancer du Poumon has over 1,600 members
- +3 more outcomes
Companies that use Patients en Réseau
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles3 records
Patients en Réseau technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature7 records
Patients en Réseau partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- Continuum+corePatients en Réseau has partnered with Continuum+ since 2017 to develop AKO@dom, AKO@PRO, and AKO@pharma digital accompaniment solutions for cancer patients on oral therapies at home. Continuum+ provides the secure digital platform enabling communication between hospital teams and community healthcare professionals (liberal nurses, pharmacists) for remote patient monitoring.
- WeFightcorePatients en Réseau partnered with startup WeFight to develop Vik® Sein, the first virtual chatbot companion for breast cancer patients. The chatbot won the Prix de la Cancérologie Connectée at RCFr 2017.
- KiplinminorPatients en Réseau partnered with Kiplin to offer physical activity programs (APA) for patients on the networks. Patients participate in challenges and physical activities together, improving their well-being through gamified exercise programs.
- Wordcom ConsultingminorWordcom Consulting serves as the press agency for Patients en Réseau, handling media relations and press inquiries for the association.
- Collectif 1310corePatients en Réseau is a founding member of the Collectif 1310, launched in 2018 to establish the National Metastatic Breast Cancer Day held annually on October 13. The collective aims to better understand and support people living with metastatic breast cancer.
- Action PatientscorePatients en Réseau is a member of Action Patients, a collective of about twenty associations committed to defending healthcare values. The collective has been mobilizing since 2020 around concerns about deteriorating access to care and quality of patient care.
- Lung Cancer Europe (LuCE)corePatients en Réseau – Mon Réseau Cancer du Poumon is a member of Lung Cancer Europe (LuCE) since April 2019. LuCE groups more than 20 national associations across Europe to advocate for people affected by lung cancer, improve early diagnosis, expand the European network, and defend equitable access to treatments.
- Digestive Cancer Europe (DiCE)corePatients en Réseau – Mon Réseau Cancer Colorectal is a member of Digestive Cancer Europe (DiCE) since July 2020. DiCE is a European organization with about thirty members representing patients with digestive cancers, contributing to early diagnosis, reducing mortality, and improving survival and quality of life.
- Union for International Cancer Control (UICC)corePatients en Réseau is a member of the UICC, founded in 1933 in Geneva, bringing together more than 1,100 member organizations in 170 countries. UICC's mission is to reduce the global cancer burden by promoting equitable access to care and maintaining cancer as a global health priority.
- AF3M (Association Française des Malades du Myélome Multiple)minorAF3M participated in the design of the AKO@dom-PICTO experimentation as a patient association partner, contributing to the coportage of the Article 51 pilot.
- Réseau de Cancérologie Grand-Est (NEON)coreNEON, the Grand-Est regional cancer network, co-porté the AKO@dom-PICTO experimentation alongside Patients en Réseau, Continuum+, URPS Pharmacists Grand Est, and Hôpitaux Universitaires de Strasbourg.
- Hôpitaux Universitaires de Strasbourg (HUS / ICANS)coreHôpitaux Universitaires de Strasbourg (now ICANS - Institut de Cancérologie Strasbourg Europe) partnered with Patients en Réseau on the AKO@dom and AKO@PRO programs, including pilot studies in metastatic kidney and breast cancer.
- URPS Pharmaciens Grand EstcoreThe Regional Union of Health Professionals (Pharmacists) of Grand Est co-porté the AKO@dom-PICTO experimentation, contributing expertise on pharmacy-based patient follow-up.
- Bristol Myers Squibb, Coloplast, Hollister, MerckminorThe 'Ma vie avec la stomie' video series was produced in partnership with Bristol Myers Squibb, Coloplast, Hollister, and Merck, providing educational content for colorectal cancer patients with stomas.
- Institutional supporters (IFCT, Institut Curie, Gustave Roussy, Institut du Thorax, ICM, Unicancer, Hôpital Cochin, AstraZeneca, Bayer, Roche, Novartis, Pfizer, MSD, Gilead, GSK, Janssen, Daiichi Sankyo, Exact Sciences, Sanofi, Servier, Takeda, Lilly, Amgen, Pierre Fabre, Bioderma, L'Oréal - La Roche-Posay, Les Franjynes, Norgine, Seagen, Rouge Gorge)minorMultiple pharmaceutical companies, cancer institutes, and healthcare organizations provide institutional support to Patients en Réseau, as evidenced by their logos displayed on the association's website supporters section.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Patients en Réseau competitors and assessment
Company assessmentDirect peers
- Cancer Support Community: US-based non-profit operating a network of community-based and online support services for cancer patients and caregivers. Directly comparable in the disease-specific online community model, although US-focused and much larger scale.
- PatientsLikeMe: US-based patient community platform focused on peer support, symptom tracking, and patient-reported outcomes research across multiple conditions including cancer. Operates a similar online community + research monetization model, although at larger scale globally.
- Carenity: French patient community platform enabling people with chronic conditions (including cancer) to share experiences and participate in real-world research. Closest direct comparator to Patients en Réseau in France, with overlapping online community model and pharma-sponsored research angle.
- Inspire: Online health community platform partnering with patient advocacy organizations and life sciences companies to run condition-specific communities and research. Directly comparable community infrastructure and pharma-sponsored research model.
Others
- Continuum+: French digital health technology partner that co-developed the AKO@dom, AKO@pro, and AKO@pharma platforms with Patients en Réseau. Technology partner and supplier of the remote monitoring infrastructure underneath the AKO programs.
- Europa Donna: European breast cancer advocacy coalition with member organizations across Europe. Thematic peer sharing the breast cancer patient advocacy mission and aligning with the DiCE/LuCE affiliation model Patients en Réseau uses.
Broad incumbents
- Ligue contre le Cancer: France's largest cancer patient non-profit providing support, research funding, and advocacy through 103 departmental committees. Broader incumbent in the same French cancer patient support space with overlapping services but a traditional federation model rather than digital-first.
- Macmillan Cancer Support: Major UK cancer support charity providing information, financial support, and community services for cancer patients. Comparable in mission and scope but operates as a much larger incumbent with broader offline services and is a European peer in the same patient support category.
Emerging players
- My Cancer Navigator: European cancer patient navigation and information service helping patients find reliable information and clinical trial access. Comparable in mission to bridge cancer patients with trustworthy information and care resources, though narrower in scope.
- Rose (Application): French app supporting women with breast cancer through community, content, and coaching. Overlaps with Mon Réseau Cancer du Sein as a French-language digital community for breast cancer patients but narrower scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Patients en Réseau social profiles
Digital presencePatients en Réseau financial estimates
Financial estimateRevenue estimate
Valuation estimate
Patients en Réseau leadership team
Management profileNumber of profiles
Profiles12 records
Patients en Réseau funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Patients en Réseau M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Patients en Réseau
What does Patients en Réseau do?
Patients en Réseau operates free, anonymous and moderated secure private social networks for cancer patients and their caregivers across five disease-specific communities (breast, lung, gynecological, colorectal cancers, and caregivers). The association complements these communities with digital remote patient monitoring tools (AKO@dom, AKO@pro, AKO@pharma) developed with Continuum+, an educational serious game (Mon Immuno Poumon), webconferences (LinK) and informational video content. All content is validated by multidisciplinary scientific committees drawn from leading French cancer institutions, and the platforms are accessible via web and mobile applications to all French speakers.
Is Patients en Réseau a public or private company?
Patients en Réseau is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Patients en Réseau founded?
Patients en Réseau was founded in 2014. It employs 11 to 50 people.
Where is Patients en Réseau based?
Patients en Réseau is headquartered in Paris, France, in the Europe region.
How does Patients en Réseau make money?
Four revenue lines are on record. Membership Dues are the primary driver. The others are donations, institutional Support and Partnerships and boutique / Product Sales.
Who are Patients en Réseau's main competitors?
Direct peers on record are Cancer Support Community, PatientsLikeMe, Carenity and Inspire. Others are Continuum+ and Europa Donna. Broad incumbents are Ligue contre le Cancer and Macmillan Cancer Support. Emerging players are My Cancer Navigator and Rose (Application).
Does Patients en Réseau have an API?
No public API is recorded for Patients en Réseau.
What industry is Patients en Réseau in?
Patients en Réseau's product category is Patient Support Services. Its primary akta.pro industry code is BPAMABAL, Health & Support Communities, with a secondary code of HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation. Its NAICS code is 6241 and its SIC code is 8300.